MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma

Tumor Biology

Volumn 37, Issue 8, 2016, Pages 11457-11467

  Feng, Xiao Jun ^a,d   Pan, Qing ^b   Wang, Shou Mei ^a   Pan, Yun cui ^a   Wang, Qian ^a   Zhang, Huan Huan ^a   Zhu, Ming Hua ^c   Zhang, Shu Hui ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b TONGDE HOSPITAL OF ZHEJIANG PROVINCE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d Changxing Hospital of Traditional Chinese Medicine   (China)

Author keywords

Epithelial mesenchymal transition; Hepatocellular carcinoma; Invasion; MAP4K4; Metastasis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; MAP4K4 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SECONDARY; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES;

EID: 84961588319     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-016-5022-1     Document Type: Article

References (25)

1. Boyle P, Levin B. World cancer report 2008. Avenue, Geneva, Switzerland: WHO Press; 2009. p. 350.
2. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010;15 Suppl 4:5–13.
3. Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol. 2014;20:10223–37.
4. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.
5. Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, et al. E-cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol. 2011;99:392–7.
6. Smith BN, Bhowmick NA. Role of EMT in metastasis and therapy resistance. J Clin Med 2016; pii: E17
7. Dong Q, Zhu X, Dai C, Zhang X, Gao X, Wei J, et al. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin. Oncotarget. 2016. doi: 10.18632/oncotarget.7016.
8. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349–61.
9. Dai W, Wang F, He L, Lin C, Wu S, Chen P, et al. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor nfat1. Mol Carcinog. 2015;54:301–11.
10. Davis FM, Stewart TA, Thompson EW, Monteith GR. Targeting EMT in cancer: opportunities for pharmacological intervention. Trends Pharmacol Sci. 2014;35:479–88.
11. Vitorino P, Yeung S, Crow A, Bakke J, Smyczek T, West K, et al. Map4k4 regulates integrin-ferm binding to control endothelial cell motility. Nature. 2015;519:425–30.
12. Yue J, Xie M, Gou X, Lee P, Schneider MD, Wu X. Microtubules regulate focal adhesion dynamics through map4k4. Dev Cell. 2014;31:572–85.
13. Collins CS, Hong J, Sapinoso L, Zhou Y, Liu Z, Micklash K, et al. A small interfering RNA screen for modulators of tumor cell motility identifies map4k4 as a promigratory kinase. Proc Natl Acad Sci U S A. 2006;103:3775–80.
14. Liu AW, Cai J, Zhao XL, Jiang TH, He TF, Fu HQ, et al. Shrna-targeted map4k4 inhibits hepatocellular carcinoma growth. Clin Cancer Res. 2011;17:710–20.
15. Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, et al. Expression of map4k4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res. 2008;14:7043–9.
16. Zhao G, Wang B, Liu Y, Zhang JG, Deng SC, Qin Q, et al. Mirna-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting map4k4. Mol Cancer Ther. 2013;12:2569–80.
17. Toiyama Y, Yasuda H, Saigusa S, Tanaka K, Inoue Y, Goel A, et al. Increased expression of slug and vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Carcinogenesis. 2013;34:2548–57.
18. Schneider MR, Hiltwein F, Grill J, Blum H, Krebs S, Klanner A, et al. Evidence for a role of E-cadherin in suppressing liver carcinogenesis in mice and men. Carcinogenesis. 2014;35:1855–62.
19. Qiu MH, Qian YM, Zhao XL, Wang SM, Feng XJ, Chen XF, et al. Expression and prognostic significance of map4k4 in lung adenocarcinoma. Pathol Res Pract. 2012;208:541–8.
20. Zohn IE, Li Y, Skolnik EY, Anderson KV, Han J, Niswander L. P38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell. 2006;125:957–69.
21. Song FN, Duan M, Liu LZ, Wang ZC, Shi JY, Yang LX, et al. Rankl promotes migration and invasion of hepatocellular carcinoma cells via NF-kappab-mediated epithelial-mesenchymal transition. PLoS One. 2014;9, e108507.
22. Song R, Song H, Liang Y, Yin D, Zhang H, Zheng T, et al. Reciprocal activation between ATPase inhibitory factor 1 and NF-kappab drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology. 2014;60:1659–73.
23. Ching YP, Leong VY, Lee MF, Xu HT, Jin DY, Ng IO. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation. Cancer Res. 2007;67:3601–8.
24. Tsai JP, Hsiao PC, Yang SF, Hsieh SC, Bau DT, Ling CL, et al. Licochalcone a suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of mkk4/JNK via NF-kappab mediated urokinase plasminogen activator expression. PLoS One. 2014;9, e86537.
25. Zhu XL, Wang YL, Chen JP, Duan LL, Cong PF, Qu YC, et al. Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition. Tumour Biol. 2014;35:1627–35.